The FDA has granted expanded access to Revolution Medicines’ targeted pancreatic cancer drug daraxonrasib, opening a pathway for more patients to receive a therapy that has shown promising results in clinical trials.
The U.S. FDA approves expanded access to daraxonrasib, a breakthrough targeted therapy for previously treated metastatic pancreatic ductal adenocarcinoma, offering new hope for patients with one of the deadliest cancers.
The US FDA approves expanded access to daraxonrasib, an innovative pancreatic cancer drug, offering new hope for patients facing one of the deadliest forms of cancer.
The FDA approves an expanded access program for daraxonrasib, an innovative pancreatic cancer drug that showed promising results in clinical trials, offering new hope for patients with one of the most challenging cancers.
Researchers from the University of Barcelona and University of Oregon develop a novel DNA-based cholesterol therapy that reduced LDL cholesterol by 47% in animal models, without statin-related side effects.
Oxford researchers demonstrate quadsqueezing — a fourth-order quantum interaction — for the first time on any platform, generating it over 100 times faster than expected using conventional approaches.
The U.S. FDA approves expanded early access for the experimental pancreatic cancer drug daraxonrasib, offering new hope for late-stage patients.
Scientists have discovered preserved blood vessel structures in 66-million-year-old T. rex fossil bones, opening unprecedented possibilities for extracting original proteins from dinosaurs.
The UK’s Office for Product Safety and Standards has issued an urgent recall for two Crayola children’s craft kits after sand in the products was found to potentially contain asbestos, the latest in a worrying string of similar recalls this year.
A Mayo Clinic-developed AI system called REDMOD can identify pancreatic cancer signatures from CT scans an average of 16 months before clinical diagnosis, with a detection rate nearly double that of human specialists.